Efficacy of Topical Imiquimod 3.75% in the Treatment of Actinic Keratosis of the Scalp in Immunosuppressed Patients: Our Case Series.

Journal of Dermatological Treatment - United Kingdom
doi 10.1080/09546634.2019.1590524
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Informa UK Limited

Related search

Imiquimod 5% Cream for the Treatment of Actinic Keratosis of the Eyelid

Beyoglu Eye Journal
2017English

Safety, Efficacy, and Patient Acceptability of Imiquimod for Topical Treatment of Actinic Keratoses

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2011English

An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses on Dorsal Hands and Forearms

Journal of the American Academy of Dermatology
Dermatology
2013English

Non-Adherence to Topical Treatments for Actinic Keratosis

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2013English

Evaluation of Resource Utilization and Treatment Patterns in Patients With Actinic Keratosis in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

Current and Emerging Treatment Strategies for the Treatment of Actinic Keratosis

Clinical, Cosmetic and Investigational Dermatology
Dermatology
2010English

Insight Into the Management of Actinic Keratosis

British Journal of Dermatology
DermatologyMedicine
2019English

880 Triptolide (TRP), a Diterpenoid, Shows a Strong Efficacy and a Safe Profile in the Topical Treatment of Actinic Keratosis Lesions in a UV-B-induced Mouse Model

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy